CRIS BISSONNETTE: Open Payments
NPI 1619216009 · BERKELEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $450
Food & beverage: $422Education: $27
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $184 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $108 |
| Axsome Therapeutics, Inc. | 1 | $32 |
Products named: COBENFY, FANAPT, UZEDY, Auvelity.
Industry payments across CA — which companies pay providers there.
